翟倩倩，博士，副研究員，碩士研究生導(dǎo)師。主要從事水產(chǎn)藥理學(xué)及健康養(yǎng)殖研究。主持國家自然科學(xué)基金、山東省自然科學(xué)基金、青島市自然科學(xué)基金、中國水產(chǎn)科學(xué)研究院基本科研業(yè)務(wù)費(fèi)重點(diǎn)項(xiàng)目等科研項(xiàng)目9項(xiàng)。發(fā)表研究論文30篇（SCI收錄22篇），以第一發(fā)明人授權(quán)國家發(fā)明專利4項(xiàng)，參編專著2部，研究成果獲中國水產(chǎn)學(xué)會范蠡科學(xué)技術(shù)獎一等獎1項(xiàng)、中國水產(chǎn)科學(xué)研究院科學(xué)技術(shù)獎二等獎1項(xiàng)。2022年入選中國水產(chǎn)科學(xué)研究院“水科英才”培育計劃拔尖人才。
通訊地址：山東省青島市南京路106號中國水產(chǎn)科學(xué)研究院黃海水產(chǎn)研究所
郵政編碼：266071
E-mail：[email protected]
主要研究內(nèi)容、研究方向：水產(chǎn)藥理學(xué)、甲殼動物健康養(yǎng)殖
代表性論文：
1. Zhai QQ, Chang ZQ, Li JT, Li J. Effects of combined florfenicol and chlorogenic acid to treat acute hepatopancreatic necrosis disease in Litopenaeus vannamei caused by Vibrio parahaemolyticus. Aquaculture, 2022, 547: 737462.
2. Zhai QQ, Chang ZQ, Li JT, Li J. Protective Effects of Combined Utilization of Quercetin and Florfenicol on Acute Hepatopancreatic Necrosis Syndrome Infected Litopenaeus vannamei. Antibiotics, 2022, 11(12): 1784.
3. Zhai QQ, Xu Y, Li CP, Feng YY, Cui YT, Ma L, Li J. Inhibition of breast cancer resistance protein (BCRP) by Ko143 can affect pharmacokinetics of enrofloxacin in Exopalaemon carinicauda. Journal of Ocean University of China, 2020, 19(5): 1116-1124.
4. Zhai QQ, Li J. Effectiveness of traditional Chinese herbal medicine, San-Huang-San, in combination with enrofloxacin to treat AHPND-causing strain of Vibrio parahaemolyticus in fection in Litopenaeus vannamei. Fish and Shellfish Immunology, 2019, 87: 360-370.
5. Zhai QQ, Li J, Feng YY, Ge QQ. Evaluation of combination effects of Astragalus polysaccharides and florfenicol against acute hepatopancreatic necrosis disease-causing strain of Vibrio parahaemolyticus in Litopenaeus vannamei. Fish and Shellfish Immunology, 2019, 86: 374-383.
6. Zhai QQ, Li J, Chang ZQ. cDNA cloning, characterization and expression analysis of ATP-binding cassette transmembrane transporter in Exopalaemon carinicauda. Aquaculture Research, 2017, 48(8): 4143-4154.
7. Zhai QQ, Pang J, Li GQ, et al. Preclinical pharmacokinetic analysis of (E)-Methyl-4-aryl-4-oxabut-2-enoate, a novel SerThr protein kinase PknB inhibitor, in rats. Acta Poloniae Pharmaceutica. 2017, 74(1): 299-307.
8. Zhai QQ, Pang J, Li GQ, et al. 2015-Validated LC-MS/MS method for determination of YH-8, a novel PKnB inhibitor, in rat plasma and its application to pharmacokinetic study. Acta Pharmaceutica Sinica B. 2015, 5(5): 467-472.
9. Feng YY, Zhai QQ, Wang JJ, Li JT, Li J. Comparison of florfenicol pharmacokinetics in Exopalaemon carinicauda at different temperatures and administration routes. 2019, 42: 230-238.
10.翟倩倩,李健. 恩諾沙星對脊尾白蝦APND、ECOD和GST活性的影響. 海洋科學(xué). 2017, 41(2): 53-60.
